IGF1 and arrhythmogenic right ventricular cardiomyopathy: Crucially, this raises the possibility that during enhanced adipogenic signaling in ARVC, IGF-1 expression in cardiac MSCs is rapidly decreased, and as a result some protection against arrhythmia is lost.